Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

UroGen to Present at November 2019 Investor Conferences


UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, today announced that it will participate in fireside chats at the following conferences in November:

Stifel 2019 Healthcare Conference

Jefferies 2019 London Healthcare Conference

A live audio webcast of each event will be available on the Investors section of UroGen's website, www.urogen.com. A replay of each webcast will be available on the website for approximately two weeks.

About UroGen Pharma Ltd.

UroGen Pharma Ltd. (Nasdaq:URGN) is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology. UroGen has developed RTGeltm reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's lead investigational candidates, UGN-101 (mitomycin gel) for instillation, and UGN-102 (mitomycin gel) for intravesical instillation, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade non-muscle invasive bladder cancer, respectively. UroGen is headquartered in New York, NY with operations in Israel.


These press releases may also interest you

at 14:30
Disaster Management Group, a South Florida-based disaster recovery firm, announced today DMGtest, a screening tool for COVID-19 that gives results in 15 minutes. The test is the first of its kind used in Florida to screen for coronavirus. DMGtest...

at 14:02
On behalf of the Québec government, Minister of Tourism Caroline Proulx today announced the closing until further notice of tourist accommodation establishments. There are two exceptions to the rule: certain campgrounds that host snowbirds who do not...

at 14:00
Confluent Health is proud to announce their newest partnership, El Paso Physical Therapy Services (EPPTS), a physical therapist-owned rehabilitation company since 1985 specializing in the treatment of orthopedic, sports, and work-related injuries...

at 11:23
Today, Samaritan's Purse deployed its Emergency Field Hospital to New York City, New York, where the local medical infrastructure is severely overwhelmed. In cooperation with the Federal Emergency Management Agency (FEMA), New York state officials,...

at 11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

at 11:00
As the impact of the Coronavirus (COVID-19) is now felt worldwide, we want to assure our customers and partners that we are still here to support you. Zenner's operations remain open with regular operating hours. Zenner's number one priority is...



News published on 18 november 2019 at 08:05 and distributed by: